ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Mobile health urinalysis diagnostic draws FDA scrutiny

Featured Story

Mobile health urinalysis diagnostic draws FDA scrutiny

May 23, 2013 11:50 am by | 0 Comments

In a move that may reflect a growing interest by the U.S. Food and Drug Administration in asserting its regulatory muscle in the mobile health app space, the regulator recently sent a letter to mobile app maker Biosense Technologies Pvt Ltd. indicating that it needs 510(k) clearance for its urinalysis ... Read more
32 life science and health IT startups will compete in MassChallenge 2013

32 life science and health IT startups will compete in MassChallenge 2013

May 23, 2013 5:08 pm by | 0 Comments

Who will win this year’s MassChallenge? The Boston accelerator is set to get its fourth session underway with the announcement of the 128 new startups that will participate. A quarter ... Read more
Online tool cut inappropriate tests from 22 percent to 6 percent

Online tool cut inappropriate tests from 22 percent to 6 percent

May 23, 2013 4:28 pm by | 0 Comments

NEW YORK (Reuters Health) - A web-based decision-making tool that alerts heart doctors when diagnostic tests would not be useful for a specific patient can curb wasteful procedures, according to ... Read more
Startups take note: Healthcare reform = opportunity

Startups take note: Healthcare reform = opportunity

May 23, 2013 4:13 pm by | 0 Comments

SAN FRANCISCO ’ The Affordable Care Act, aka health care reform, aka Obamacare, is spurring a massive creation of new business opportunities. So says Bryan Sivak, the chief technical officer ... Read more
Nurses want “healthcare versions” of user-friendly personal apps

Nurses want “healthcare versions” of user-friendly personal apps

May 23, 2013 4:00 pm by | 0 Comments

Nurses are the unsung heroes of the hospital who navigate crappy software on outdated hardware to keep you healthy ’ and it needs to stop. Executives from Cedar’s-Sinai and Kaiser ... Read more
“Munchies” aside, pot smokers’ waists smaller than non-users

“Munchies” aside, pot smokers’ waists smaller than non-users

May 23, 2013 3:43 pm by | 0 Comments

NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels of insulin resistance - a diabetes precursor - than those ... Read more
To advance nerve regeneration tech, Vanderbilt, AxoGen share $1.1M DOD grant

To advance nerve regeneration tech, Vanderbilt, AxoGen share $1.1M DOD grant

May 23, 2013 2:39 pm by | 0 Comments

AxoGen, a medical device company that develops peripheral nerve repair technology is splitting a $1.1 million grant from government medical research program with Vanderbilt University. The grant comes from the ... Read more
Nephosity’s medical image viewing app gets FDA nod for use in remote diagnosis

Nephosity’s medical image viewing app gets FDA nod for use in remote diagnosis

May 23, 2013 2:14 pm by | 0 Comments

The FDA has given the OK to digital health startup Nephosity to market its image viewing mobile app for diagnostic purposes.Nephosity said it receive 510(k) clearance for use of its ... Read more
Patent rights on coronavirus delay development of diagnostic tests

Patent rights on coronavirus delay development of diagnostic tests

May 23, 2013 2:04 pm by | 0 Comments

GENEVA (Reuters) - The World Health Organization (WHO) warned countries with possible cases of the SARS-like novel coronavirus on Thursday that they must share information and not allow commercial labs ... Read more
Despite recommendation, mammagram numbers didn’t go down

Despite recommendation, mammagram numbers didn’t go down

May 23, 2013 2:02 pm by | 0 Comments

NEW YORK (Reuters Health) - Women in their 40s didn't cut back on mammograms during 2010, the year after a government-backed panel said annual breast cancer screening should be optional ... Read more
Scientists reject dramatic findings on cancer drug in Alzheimer’s mice

Scientists reject dramatic findings on cancer drug in Alzheimer’s mice

May 23, 2013 1:59 pm by | 0 Comments

CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was ... Read more
Excercise in school: Battle obesity and excel academically

Excercise in school: Battle obesity and excel academically

May 23, 2013 1:31 pm by | 0 Comments

WASHINGTON (Reuters) - U.S. schools need to boost efforts to get students moving, and make gym class as critical as other core subjects if they want to increase test scores ... Read more
Already a diabetes drug, trial confirms weight loss application

Already a diabetes drug, trial confirms weight loss application

May 23, 2013 12:57 pm by | 0 Comments

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people treated with its liraglutide drug had an 8 percent weight loss."These ... Read more
Kaiser eyes expansion in Oahu, has $320M statewide plan

Kaiser eyes expansion in Oahu, has $320M statewide plan

May 23, 2013 11:55 am by | 0 Comments

Kaiser Permanente Hawaii is in discussions with Moanalua Golf Club to acquire 10 acres of the course adjacent to its flagship Oahu hospital for $4 million.An aging population and expected ... Read more
Remote Medical scores $8M grant, predicts 60 percent revenue growth

Remote Medical scores $8M grant, predicts 60 percent revenue growth

May 23, 2013 11:29 am by | 0 Comments

Seattle-based Remote Medical just scored $8 million to bring health care to virtually anyone in need, anywhere in the world. Remote Medical serves companies and individuals in remote places; it’s ... Read more
After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

After a restructure and an axed Merck deal, Acumen gains $20M for novel Alzheimer’s drug

May 23, 2013 10:29 am by | 0 Comments

It’s been 17 years in the making, but Acumen Pharmaceuticals hasn’t given up hope for its approach to a disease-modifying drug for Alzheimer’s disease. After restructuring to become a virtual ... Read more